Dr. Amrita Ghosh explains the difference between muscle loss and fat loss. And if you drop weight too fast, it can destroy your long-term metabolic rate.

Share on Pinterest Mounjaro helps maintain weight loss at 3-year landmark, study confirms. Image credit: NurPhoto/Getty Images. According to a new study, a once-weekly dose of tirzepatide can lead to ...

Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity. A new analysis of the SURMOUNT clinical trials reveals that the medicine, ...

In the context of the global obesity epidemic, the FDA approved several glucagon-like peptide-1 (GLP-1) receptor agonists (GPL-1RAs), such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) as ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

A new once-a-month injection helped people with obesity shed up to 16% of their body weight, offering fresh hope for effective, long-acting treatments. Can this breakthrough change the landscape for ...